29-Jan-2026
TipRanks (Thu, 29-Jan 8:22 AM ET)
TipRanks (Thu, 29-Jan 6:21 AM ET)
Analysts Are Bullish on These Healthcare Stocks: Bristol-Myers Squibb (BMY), HCA Healthcare (HCA)
TipRanks (Thu, 29-Jan 3:31 AM ET)
Barclays Remains a Buy on Elevance Health (ELV)
TipRanks (Thu, 29-Jan 3:30 AM ET)
Elevance Health Earnings Call Flags Reset Before Rebound
TipRanks (Wed, 28-Jan 7:14 PM ET)
U.S. stocks end flat as Fed pauses rate cuts; Nasdaq rises as chip stocks rally
Seeking Alpha News (Wed, 28-Jan 4:07 PM ET)
Wall Street is mixed as Fed pauses rate cuts amid big tech earnings, geopolitical turmoil
Seeking Alpha News (Wed, 28-Jan 2:33 PM ET)
Wall Street is mixed as Fed pauses rate cuts amid bit tech earnings, geopolitical turmoil
Seeking Alpha News (Wed, 28-Jan 2:33 PM ET)
Seeking Alpha News (Wed, 28-Jan 1:06 PM ET)
Seeking Alpha News (Wed, 28-Jan 11:46 AM ET)
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Elevance Health trades on the NYSE stock market under the symbol ELV.
As of January 29, 2026, ELV stock price climbed to $346.98 with 2,087,944 million shares trading.
ELV has a beta of 0.26, meaning it tends to be less sensitive to market movements. ELV has a correlation of 0.02 to the broad based SPY ETF.
ELV has a market cap of $77.11 billion. This is considered a Large Cap stock.
Last quarter Elevance Health reported $49 billion in Revenue and $3.33 earnings per share. This fell short of revenue expectation by $-161 million and exceeded earnings estimates by $.23.
In the last 3 years, ELV traded as high as $567.26 and as low as $273.71.
The top ETF exchange traded funds that ELV belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
ELV has underperformed the market in the last year with a price return of -11.6% while the SPY ETF gained +16.5%. However, in the short term, ELV had mixed performance relative to the market. It has outperformed in the last 3 months, returning +3.7% vs +1.3% return in SPY. But in the last 2 weeks, ELV shares have been beat by the market, returning -9.2% compared to an SPY return of +0.3%.
ELV support price is $336.66 and resistance is $347.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ELV shares will trade within this expected range on the day.